What is TRNS's market cap?

$1.01B, based on the Nov 4 close of $108.13.

What is TRNS's P/E ratio?

220.5× trailing-twelve-month earnings of $4.59M.

Does Transcat pay a dividend?

No regular cash dividend has been paid in the last year.

How much of TRNS is sold short?

441.9K shares, 4.9% of float, as of Oct 15, 2026.

What sector is TRNS in?

Technology, in the Electronic Instruments industry.

NASDAQ · TRNSTechnologyElectronic Instruments

Transcat Inc (TRNS)

$108.13+20.79%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$107.45▲ 52.15% in range

Nov 3, 2025Low $52.06 · High $107.45Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Transcat closed at $108.13 on Nov 4, up 20.79% — matching its 52-week closing high. Volume of 700.8K shares was 4.69× its 20-day average (well above normal).

Split-adjusted performance: +20.4% over one month, +43.9% over six months, +53.1% over one year.

In the quarter ended Sep 26, 2026, revenue was $97.09M, up 18.0% from a year earlier, with a net margin of 2.5%.

Short interest was 441.9K shares at the Oct 15 settlement, down 5.8% from the prior report (4.9% of float, 4.0 days to cover).

Market cap$1.01B9.4M shares

Revenue · quarter$97.1M+18.0% YoY

Diluted EPS$0.25+78.6% YoY

P/E · TTM220.5×P/S 2.8×

Net margin2.5%Gross 33.6%

Dividend yieldNone

52-week range52.06 – 108.130.0% from high

Volume700.8K4.69× 20-day avg

Volatility · 60d54.2%Annualised

Short % of float4.9%4.0 days to cover

Net cash-$111.1MCash $5.8M

Next earnings—Not scheduled

Split-adjusted performance

1W +21.7%1M +20.4%3M +14.4%6M +43.9%YTD +90.6%1Y +53.1%3Y +15.9%5Y +47.1%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Electronic Instruments

Percentile among 10 companies (100 = best)

6-month momentum100

Revenue growth50

Net margin33

Value (low P/E)—

Size33

Industry medians: 6-month return −4.4%, revenue growth +18.0%, net margin 6.9%, P/E 47.3×.

Short interest

Details →

Shares short441.9K−5.8% vs prior

Days to cover4.0Settled Oct 15

% of float4.9%

Short vol. 10d36.6%of daily volume

Closest peers by size in Electronic Instruments

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
TRNSTranscat	$108.13	+20.79%	+43.9%	+18.0%	2.5%	220.5	$1.01B
ALNTAllient	$79.56	−9.61%	+2.6%	+10.2%	6.8%	47.3	$1.35B	Compare
FEIMFrequency Electronics	$61.52	−7.61%	+7.6%	+69.8%	18.0%	258.9	$693.5M	Compare
AEHRAehr Test Systems	$60.84	−6.56%	−37.1%	−43.7%	−31.1%	—	$1.99B	Compare
COHUCohu	$43.98	−12.09%	−11.4%	+37.0%	7.0%	—	$2.08B	Compare
ITRIItron	$101.60	+3.44%	+22.5%	+3.0%	11.9%	15.9	$4.46B	Compare
INTTinTEST	$14.00	−4.63%	−19.6%	+25.5%	1.3%	114.5	$179.6M	Compare
VLTOVeralto	$117.02	+0.60%	+34.7%	+7.5%	16.8%	28.4	$28.45B	Compare
TERTeradyne	$250.99	−6.82%	−34.4%	+69.8%	26.2%	28.5	$39.19B	Compare

News about Transcat

All news →

Can Transcat (TRNS) Keep the Earnings Surprise Streak Alive?Zacks Investment Research · 6d ago▲ Positive

Quick answers

What does Transcat do?: Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities.
What is TRNS's market cap?: $1.01B, based on the Nov 4 close of $108.13.
What is TRNS's P/E ratio?: 220.5× trailing-twelve-month earnings of $4.59M.
Does Transcat pay a dividend?: No regular cash dividend has been paid in the last year.
How much of TRNS is sold short?: 441.9K shares, 4.9% of float, as of Oct 15, 2026.
What sector is TRNS in?: Technology, in the Electronic Instruments industry.

About Transcat

Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.

HQ: Rochester, NY1,413 employeesListed Dec 5, 1977transcat.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology